A total of six patients were scheduled for entry at dose level 4, but each of the first four patients treated at this dose level suffered multiple grade 2 toxicities and a further two patients experienced a grade 3 toxicity.
The route of entry, the dose and the duration of nanoparticles into the human body have a significant effect on the extent and severity of the toxicity [16].
Despite this pronounced negative mysterian note (see section 3.1 of the main entry), Augustine dose seem to have a rudimentary metaphysics of the Trinity, which he uncritically receives, and does not think can be significantly developed.
Details of the seven included studies, together with entry criteria, dose and duration of treatment, outcomes and quality and validity scores are shown in (additional file 1).
The clinical manifestations and severity of illness after infection with F. tularensis depend on the portal of entry, infectious dose, virulence of the organism, and immune status of the infected person; despite the organism's high infectivity, asymptomatic infection with F. tularensis is known to occur.
Dose adjustment was required in 31%% (115/372) of prescription entries and fifty eight (51%%) prescription entries requiring dose adjustment were found to be inappropriate.
The reason for the difference in results between the two studies is unclear since the studies had identical designs, including entry criteria, doses of study medication, and outcome measures.
Assumptions were made on an ad hoc basis blind-to-treatment allocation for the 2.4% of drug entries where doses and drug combinations failed to match perfectly to the recommended dosing structure.
Patients who had received antifungals for ≤48 h before study entry (one echinocandin dose maximum) without improvement were eligible.
Visual alarms on sampling time, hypoglycemia, and nutrition dose entry errors are also included in the software.
